Delivery Order SPE2DR25D3304-SPE2DR26F48G5
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10,756.42 to AmerisourceBergen Drug Corp for the supply of Jardiance 10mg tablets (90-count) on November 18, 2025, with completion scheduled for December 16, 2025. This firm fixed-price, non-set-aside contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $8,921.73 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on January 7, 2026, with completion expected by January 8, 2026. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as...
- The Defense Logistics Agency awarded a $15,851.21 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 7, 2026, for the supply of Jardiance 25 mg tablets (90-count units). The contract, designated as a non-set-aside competitive award, is scheduled for completion by January 8, 2026, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $9,732.24 on January 7, 2026, for the supply of Jardiance 25 mg tablets (90-count packages). The contract is a firm fixed-price delivery order with no set-aside designation, awarded by the Defense Logistics Agency (DLA), the Department of Defense's supply chain management organization responsible for medical procurement. Performance will be completed...
- The Defense Logistics Agency awarded a delivery order valued at $10,436.38 to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Jardiance 10 mg tablets in quantities of 90. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, with an ultimate completion date of July 15, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $11,643.53 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packaging) with a completion date of December 16, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's substantial pharmaceutical supply...
- The Defense Logistics Agency awarded a $16,600.69 firm fixed price delivery order to AmerisourceBergen Drug Corp for Jardiance 10 mg tablets (90-count supply) with an ultimate completion date of October 27, 2025. This non-set-aside contract was competitively awarded and represents a delivery order against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical will be supplied to the Conshohocken, Pennsylvania location where...
- The Defense Logistics Agency awarded a delivery order valued at $12,257.52 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units). The contract was competitively awarded without set-aside designation under a firm fixed-price delivery order structure, with an ultimate completion date of September 10, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $8,908.09 by the Defense Logistics Agency for 90 tablets of Jardiance 10 mg, a diabetes management medication. The contract is a firm fixed-price delivery order with an ultimate completion date of September 22, 2025, and represents a non-set-aside competitive award. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $18,079.54 to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Jardiance 10 mg tablets in a 90-count quantity. The contract, which is not set-aside, carries a firm fixed price structure with an ultimate completion date of December 8, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery...
- SPE2DR25D3304Indefinite Delivery Contract
- SPE2DR25D3304-SPE2DR26F48G5Delivery Order
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $8,048.54 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) on January 7, 2026, with an ultimate completion date of January 8, 2026. The order carries no set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999.99 billion through December 2026), which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply an extensive range of medications and medical commodities to military healthcare programs and defense medical systems worldwide. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal medical procurement needs across multiple therapeutic domains. The company has demonstrated consistent capability in competitively awarded federal contracts covering prescription medications, vaccines, medical devices, and specialized healthcare commodities. This order for Jardiance—a diabetes medication—reflects the company's role in supporting Defense Health Agency medical supply requirements and represents one of numerous delivery orders executed under the broader pharmaceutical prime vendor contract structure that enables flexible fulfillment of military healthcare demands.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.0k | 1/6/26 |